Clinical Trial Update: Real-life Study of Patients After 3-months of Leuprorelin 5mg Implant in Prostate Cancer

View source ↗

Summary

This trial evaluating real-life use of a leuprorelin 5 mg implant in prostate cancer patients has been withdrawn. No results were reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Leuprorelin implant (5 mg) (leuprorelin)

Snippet

Sponsor: RECORDATI GROUP | Conditions: Prostate Cancer | Status: WITHDRAWN